<DOC>
	<DOCNO>NCT01066026</DOCNO>
	<brief_summary>The purpose study assess safety efficacy new metallic cannula inject hyaluronic acid dermal augmentation nasolabial fold compare standard needle .</brief_summary>
	<brief_title>Comparison Safety Efficacy Metallic Cannula Versus Standard Needle Inject Hyaluronic Acid Nasolabial Fold</brief_title>
	<detailed_description>This monocentric , prospective , randomize , phase II double-blind study . At baseline visit , one investigator rat severity nasolabial fold leave right side accord mention scale , standard set six photographs face ( frontal , leave side right side whole face lower face ) take . On day injection , main investigator inject 1ml dermal filler - hyaluronic acid ( RestylaneÂ® , Q-Med , Uppsala , Sweden ) - subject . The injected amount 0,5ml right nasolabial fold 0,5ml leave nasolabial fold . The side randomize .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subjects agree take part study , fully inform purpose nature investigation sign informed consent form Female subject age 18 60 Fitzpatrick phototype I VI Presence bilateral fold grade 2 3 accord Modified Fitzpatrick Wrinkle Scale Subjects never perform treatment nasolabial fold Female subject childbearing age present negative urine pregnancy test use effective contraceptive method Subjects available throughout duration study Subjects sufficient school awareness enable cooperate degree require protocol . Use systemic corticosteroid History herpes lip Inflammation active infection area inject Any surgical treatment cosmetic procedure area inject interfere study 's outcome Coagulation disorder use anticoagulant Previous hypersensitivity response Hyaluronic acid . Pregnant woman breastfeed , woman plan become pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>metallic cannula</keyword>
	<keyword>Hyaluronic acid</keyword>
</DOC>